Compare ABVX & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | ALSN |
|---|---|---|
| Founded | 2013 | 1915 |
| Country | France | United States |
| Employees | 69 | 4000 |
| Industry | | Auto Parts:O.E.M. |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.5B |
| IPO Year | N/A | 2011 |
| Metric | ABVX | ALSN |
|---|---|---|
| Price | $126.64 | $117.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 7 |
| Target Price | ★ $131.31 | $117.57 |
| AVG Volume (30 Days) | ★ 948.8K | 860.9K |
| Earning Date | 03-23-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.49 |
| Revenue | N/A | ★ $3,010,000,000.00 |
| Revenue This Year | $52.14 | $94.98 |
| Revenue Next Year | $4,132.27 | $5.30 |
| P/E Ratio | ★ N/A | $88.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $67.15 | $76.01 |
| 52 Week High | $148.83 | $137.62 |
| Indicator | ABVX | ALSN |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 51.78 |
| Support Level | $107.67 | $110.17 |
| Resistance Level | $130.50 | $118.64 |
| Average True Range (ATR) | 5.21 | 4.06 |
| MACD | -1.29 | 0.19 |
| Stochastic Oscillator | 38.93 | 50.71 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.